<The >effects of weight and injected dose in the liver’s Signal-to-Noise Ratio in patients submitted to PET/CT scans by Duarte, Diogo Teixeira da Silva
 
 
!Instituto!Politécnico!de!Coimbra!
Escola!Superior!de!Tecnologia!da!Saúde!Coimbra!
 
 
 
 
The$effects$of$weight$and$injected$dose$
in$the$liver’s$Signal6to6Noise$Ratio$in$
patients$submitted$to$PET/CT$scans$
!
$
$
Diogo!Teixeira!da!Silva!Duarte!
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
Mestrado$em$Ciências$Nucleares$Aplicadas$na$Saúde$
2011/2013$
 
 
 
 
!Instituto!Politécnico!de!Coimbra!
Escola!Superior!de!Tecnologia!da!Saúde!Coimbra!
 
Mestrado em Ciências Nucleares Aplicadas na Saúde$
Projecto/Estágio/Dissertação 
 
 
The$effects$of$weight$and$injected$dose$
in$the$liver’s$Signal6to6Noise$Ratio$in$
patients$submitted$to$PET/CT$scans$
!
$
$
Diogo!Teixeira!da!Silva!Duarte$
$
$
$
$
$
$
Orientador:$$
Prof.$Dr.$Francisco$José$Cerqueira$Alves$
Prof.$Dr.$Wim$van$den$Broek$
$
Coimbra,$Dezembro,$2013$
Acknowledgments 
 
The making of this Masters’ Dissertation was only possible thanks to the collaboration and 
the contribution, directly or indirectly, of a lot of people and institutions, which I would like to 
send my deepest thanks and appreciation, in particular: 
To my professor and supervisor in Portugal Francisco Alves, for the opportunity he gave me 
to do an international internship, for the willingness to guide me in this adventure and his 
precious help on making this an experience to help me open new doors in the future; 
To the responsible at the International Office at College of Health Technology of Coimbra, 
Rui Branco Lopes, for all the precious help he gave me in contacting Nijmegen and for all the 
willingness and information he showed and gave in making this possible; 
To my supervisor in Nijmegen and superintendent technologist Wim van den Broek for 
welcoming me in the Nuclear Medicine Department in Radboud University MC, for giving me 
the chance to gain more knowledge and experience in this area, for all the guidance he gave 
me throughout the whole internship, for all the help he always demonstrated, for the valuable 
tips and indications to make this dissertation, for reviewing every work I made in order to get 
even better and for making me feel part of the staff; 
To the Nuclear Medicine Technologist Merijn Janssen for all the guidance and help he gave 
me in order to complete my project but also for helping me in my internship, on dealing with 
all the protocols involved in scanning patients, on giving me hints and help on interacting with 
patients and for all the support he gave me; 
To the Nuclear Medicine Technologists Jurrian Butter, Marie-Claire Attard, Michel de Groot, 
Peter Kok, Eddy Mijnheere, Diana Valks, Martin Engels, Marga Ouwens, Marjo van de Ven 
and Bernadette Bosveld for all the help and support they gave me on my internship; 
To the Nuclear Medicine physician Dennis Vriens for helping me in all the mathematics 
theory and calculations and for pointing me in the right direction on how to perform my study 
and reach new insights; 
To all the Nuclear Medicine physicians for all their help and willingness on explaining me 
procedures and analysing scans; 
 
To all the Nuclear Medicine department staff for all their kindness and help on making me 
feel integrated during this internship; 
To my friends for their support, friendship and help; 
Last but not least, to my parents, Lúcia Duarte and Guilherme Duarte, for all their support 
and efforts to make this internship possible; to my brother and his mate, Nuno Duarte and 
Magda Oliveira for all their support; to my god parents, Teresa Teixeira and Augusto, for all 
their support and effort; and to my girlfriend, Sara Raimundo, for all her support, 
companionship, patience, help and comprehension during this five months of internship.  
 
To everyone, my deepest appreciation and eternal gratitude. 
Index 
 
Illustrations, graphs and tables index ................................................................ 4 
Abbreviations ..................................................................................................... 5 
Resumo ............................................................................................................. 6 
Summary ........................................................................................................... 7 
Introduction ........................................................................................................ 8 
Material and Methods ........................................................................................ 9 
PET/CT ........................................................................................................... 9 
18F-Fluorodeoxyglucose .............................................................................. 12 
Pathophysiology of Glucose and FDG’s Biodistribution ............................ 12 
FDG “Trapping” ......................................................................................... 13 
Physiological and Para-Physiological Distribution of FDG ........................ 14 
Normal FDG uptake in the liver .................................................................... 16 
Body Mass Index .......................................................................................... 17 
Procedure ..................................................................................................... 19 
Results and Discussion ................................................................................... 25 
Conclusion ....................................................................................................... 46 
References ...................................................................................................... 47 
Appendix ......................................................................................................... 49 
 !
 
Masters in Nuclear Science Applied to Health, ESTESC 
The effects of weight and injected dose in the liver’s Signal-to-Noise Ratio in patients submitted to PET/CT scans 
Diogo Teixeira da Silva Duarte  4 
 
Illustrations, graphs and tables index 
Illustration 1 - Example of CT image (left), FDG-PET image (middle) and FDG-PET/CT image (right) . 8 
Illustration 2 - Example of PET/CT scanner .......................................................................................... 11 
Illustration 3 - Examples of normal FDG uptake ................................................................................... 15 
Illustration 4 - Normal liver uptake (left) and abnormal liver uptake (right) ............................................ 16 
Illustration 5 - Positioning of the point in the CT scan ........................................................................... 21 
Illustration 6 - Positioning of the point in the PET WB scan .................................................................. 21 
Illustration 7 - Positioning of the point in the PET WB EANM scan ....................................................... 21 
Illustration 8 - First ROI on CT (left), PET WB (middle) and PET WB EANM (right) ............................. 22 
Illustration 9 - Second ROI on CT (left), PET WB (middle) and PET WB EANM (right) ........................ 22 
Illustration 10 - Third ROI on CT (left), PET WB (middle) and PET WB EANM (right) .......................... 22 
Illustration 11 - Fourth ROI on CT (left), PET WB (middle) and PET WB EANM (right) ....................... 22 
Illustration 12 - Fifth ROI on CT (left), PET WB (middle) and PET WB EANM (right) ........................... 22 
Illustration 13 - Values of the ROI's in the PET WB .............................................................................. 23 
Illustration 14 - Values of the ROI's in the PET WB .............................................................................. 23 
Illustration 15 - Table of every value of every patient of PET WB ......................................................... 24 
Illustration 16 - Relation between weight and SNR*liver in Clinical and EANM reconstructions ............. 35 
Illustration 17 - The highest SNR .......................................................................................................... 42 
Illustration 18 - SNR of a 70 Kg Patient ................................................................................................ 42 
Illustration 19 - SNR of an 86 Kg Patient .............................................................................................. 42 
Illustration 20 - SNR of an 86 Kg Patient .............................................................................................. 43 
Illustration 21 - The lowest SNR ............................................................................................................ 43!
 
Graphs 1 - Relation between Weight and Dose Injected on the PET WB (left) and PET WB EANM (right) . 25 
Graphs 2 - Relation between BMI and Dose Injected on the PET WB (left) and PET WB EANM (right) ...... 25 
Graphs 3 - Relation between Dose Injected and SNR on the PET WB (left) and PET WB EANM (right) ..... 26 
Graphs 4 - Relation between BMI and SNR on the PET WB (left) and PET WB EANM (right) ..................... 26 
Graphs 5 - Relation between Weight and SNR on the PET WB (left) and PET WB EANM (right) ................ 27 
Graphic 6 - Linear line for weight and dose injected ...................................................................................... 28 
Graphs 7 - Relation between SNR and ACliver from 5 to 3600s and 30 to 900s respectively ......................... 34 
Graphs 8 - Relation between weight and New SNRliver based on Power and Exponential Formula .............. 37 
Graphs 9 - Relation between Weight and New Dose based on Power and Exponential Formula ................ 38 
Graphs 10 - Relation between new Dose and New SNRliver based on Power and Exponential Formula ...... 38 
Graphic 11 - Relation between the dose injected and the new dose based on Power Formula .................... 39 
Graphic 12 - Relation between the dose injected and the new dose based on Exponential Formula ........... 39 
Graphic 13 - Equations for dosing schemes according to different references ............................................. 41 
 
Table 1 - BMI Categories ............................................................................................................................... 17 
Table 2 - Relation between liver's AC and SNR based on measurements on a Ga-86/Ge-68 phantom ....... 34 
Table 3 - Regressors (r1 and r2) and fit quality (R2) between SNR*liver and different measures of body size (W 
and BMI) ......................................................................................................................................................... 35 
Table 4 - Difference between injected doses, new doses and total effective doses ...................................... 40 
Table 5 - Equations for non-linear dosing according to several references ................................................... 40 
 
Masters in Nuclear Science Applied to Health, ESTESC 
The effects of weight and injected dose in the liver’s Signal-to-Noise Ratio in patients submitted to PET/CT scans 
Diogo Teixeira da Silva Duarte  5 
 
Abbreviations 
 
PET – Positron Emission Tomography 
CT – Computed Tomography 
LOR – Line of Response 
18F-FDG – 18F-Fluorodeoxyglucose 
SNR – Signal-to-Noise Ratio 
ROI – Region of Interest 
BMI – Body Mass Index 
MBq – Megabecquerel 
WB – Whole Body 
EANM – European Association of Nuclear Medicine 
MRI – Magnetic Resonance Imaging 
NHS – National Health Service 
SD – Standard Deviation 
CT-LD – Computed Tomography Low Dose 
FWHM – Full width at half maximum 
 
Masters in Nuclear Science Applied to Health, ESTESC 
The effects of weight and injected dose in the liver’s Signal-to-Noise Ratio in patients submitted to PET/CT scans 
Diogo Teixeira da Silva Duarte  6 
 
Resumo 
 
A qualidade da imagem em exames de PET/CT 18F-FDG em pacientes obesos encontra-se, 
geralmente, diminuída. Este estudo pretende avaliar, retrospectivamente, a relação entre a 
SNR, peso e dose injectada em 65 pacientes, com uma variação de peso entre 35 a 120 kg, 
com exames efectuados utilizando o modelo Biograph mCT num protocolo standard no 
departamento de Medicina Nuclear do Centro Médico Universitário de Radboud em 
Nijmegen, Holanda. 
Foram efectuados cinco ROI’s no fígado, órgão que na teoria tem um metabolismo 
homogéneo, no mesmo local, em cinco cortes consecutivos nos exames PET/CT para obter 
os valores da média de captação (sinal) e o seu desvio-padrão (ruído). A relação de ambos 
dá-nos a relação Sinal-Ruído no fígado. Com o auxílio de uma folha de cálculo, o peso, a 
altura, a SNR e o Índice de Massa Corporal foram calculados e os gráficos foram realizados 
de maneira a obter a relação entre estes factores. Os gráficos demonstraram que a SNR 
diminuía assim que o peso e/ou o IMC aumentava, assim como também demonstrou que a 
SNR também diminuía com o aumento da dose injectada. Isto é devido ao facto de 
pacientes mais pesados receberem uma dose mais elevada e, como já foi referido, 
pacientes mais pesados têm menor SNR. Estas descobertas sugerem que a qualidade das 
imagens, medidas pela SNR, que foram adquiridas em pacientes pesados, são inferiores do 
que em pacientes magros, apesar das doses mais elevadas.  
Tendo isto em consideração, foi necessário conceber uma nova fórmula para calcular a 
nova dose a injectar em pacientes, conseguindo uma SNR boa e constante em todos. 
Através de cálculos matemáticos, foi possível alcançar duas novas equações que davam 
uma imagem com uma SNR de um exame feito com um peso de referência específico (86 
kg foi o considerado) que era independente do peso do paciente. Este estudo implica que, 
com estas novas fórmulas, os pacientes mais pesados que o peso de referencia, irão 
receber uma dose mais elevada e os pacientes mais magros irão receber uma dose mais 
baixa. A mediana sendo de 86 kg, a nova dose e o novo SNR foram calculados e concluiu-
se que a qualidade das imagens mantém-se praticamente constante à medida que o peso 
aumenta e a quantidade necessária de FDG mantém-se quase a mesma, sem aumentar os 
custos da quantidade total necessária de FDG utilizada nestes pacientes. 
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Summary 
 
The quality of the image of 18F-FDG PET/CT scans in overweight patients is commonly 
degraded. This study evaluates, retrospectively, the relation between SNR, weight and dose 
injected in 65 patients, with a range of weights from 35 to 120 kg, with scans performed 
using the Biograph mCT using a standardized protocol in the Nuclear Medicine Department 
at Radboud University Medical Centre in Nijmegen, The Netherlands.  
Five ROI’s were made in the liver, assumed to be an organ of homogenous metabolism, at 
the same location, in five consecutive slices of the PET/CT scans to obtain the mean uptake 
(signal) values and its standard deviation (noise). The ratio of both gave us the Signal-to-
Noise Ratio in the liver. With the help of a spreadsheet, weight, height, SNR and Body Mass 
Index were calculated and graphs were designed in order to obtain the relation between 
these factors. The graphs showed that SNR decreases as the body weight and/or BMI 
increased and also showed that, even though the dose injected increased, the SNR also 
decreased. This is due to the fact that heavier patients receive higher dose and, as reported, 
heavier patients have less SNR. These findings suggest that the quality of the images, 
measured by SNR, that were acquired in heavier patients are worst than thinner patients, 
even though higher FDG doses are given.  
With all this taken in consideration, it was necessary to make a new formula to calculate a 
new dose to give to patients and having a good and constant SNR in every patient. Through 
mathematic calculations, it was possible to reach to two new equations (power and 
exponential), which would lead to a SNR from a scan made with a specific reference weight 
(86 kg was the considered one) which was independent of body mass. The study implies that 
with these new formulas, patients heavier than the reference weight will receive higher doses 
and lighter patients will receive less doses. With the median being 86 kg, the new dose and 
new SNR was calculated and concluded that the quality of the image remains almost 
constant as the weight increases and the quantity of the necessary FDG remains almost the 
same, without increasing the costs for the total amount of FDG used in all these patients. 
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Introduction 
 
PET/CT with 18F-Fluorodeoxyglucose has been one of the most widely used imaging 
modality to diagnose a variety of pathologies. The image quality of this kind of procedure is 
crucial in order to make a correct diagnosis. This is dependent on having a high sensitivity 
and having a good detection due to fast scintillation rate and low dead times by scintillation 
crystals which result in a better count rate performance [1–5]. Over the years, there have 
been lots of advances in this technology, which led to better image quality thanks to less-
noisy CT-based attenuation correction and better performance of scintillator crystals as 
detectors [6].  
Although there have been remarkable advances, the quality of PET/CT images on 
overweight patients is often degraded [7–9]. This can turn into a situation where the 
physician can’t separate pathology from noise, leading to false scan results. There have 
been studies, where some suggested optimizing acquisition times, while others suggest 
optimizing the injected dose of the radiopharmaceuticals in order to improve the image 
quality [5,7,8]. However, recommended doses of 18F-Fluorodeoxyglucose per kilogram of 
body weight are different from each country, leading to uncertainty whether a high injected 
dose is really necessary or if a longer scan time is the best solution [5,7,10]. 
The aim of this master’s dissertation is to study, retrospectively, the relation between Signal-
to-Noise Ratio, the injected dose and the weight on a number of patients with a wide range of 
weights on scans performed in the Nuclear Medicine Department of the Radboud University 
Medical Centre in Nijmegen, The Netherlands. The purpose is to see if there is a direct 
relation between these factors and if the image quality can be improved in heavy patients 
with a different approach. 
 
 
Illustration 1 - Example of CT image (left), FDG-PET image (middle) and FDG-PET/CT image (right) 
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Material and Methods 
 
PET/CT 
 
Nuclear medicine nowadays has gone through a lot of technological evolution. One of the 
most known techniques is positron emission tomography, also called PET. This type of scan 
is one of the most frequently used molecular imaging procedures. Molecular imaging is a 
type of medical imaging that provides detailed images of what is happening inside the body 
at a molecular and cellular level [2,4]. Other diagnostic imaging procedures, like x-rays, 
computed tomography (CT), and ultrasound predominantly offer anatomical pictures but 
molecular imaging allows physicians to see how the body is functioning and to measure its 
chemical and biological processes [6]. Molecular imaging offers unique insights into the 
human body that enable physicians to personalize patient care. In terms of diagnosis, 
molecular imaging is able to:   
 
• Give information that is unattainable with other imaging technologies or that would 
require more invasive procedures such as biopsy or surgery [2,3]; 
• Identify disease in its earliest stages and determine the exact location of the disease, 
often before symptoms occur or abnormalities can be detected with other diagnostic 
tests (i.e. detection sensitivity) [2–4]. 
 
It is also a tool for evaluating and managing the care of patients, since molecular imaging 
studies help physicians to: 
 
• Determine the extent or severity of the disease, including whether it has spread 
elsewhere in the body; 
• Select the most effective therapy based on the unique biologic characteristics of the 
patient and the molecular properties of a disease; 
• Determine a patient’s response to specific drugs; 
• Accurately assess the effectiveness of a treatment regimen; 
• Adapt treatment plans quickly in response to changes in cellular activity; 
• Assess disease progression; 
• Identify recurrence of disease and help manage on-going care. 
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When disease occurs, the biochemical activity of cells begins to change. For example, 
cancer cells multiply at a much faster rate and use more glucose than normal cells. Brain 
cells affected by dementia consume less energy than normal brain cells. Heart cells deprived 
of adequate blood flow are dysfunctional (hibernating), although they can still be viable. As 
disease progresses, this abnormal cellular activity begins to affect body tissue and 
structures, causing anatomical changes that may be seen on CT or magnetic resonance 
imaging (MRI) scans [1,4]. For example, cancer cells may form a mass or tumour. With the 
loss of brain cells, overall brain volume may decrease or affected parts of the brain may 
appear different in density than the normal areas. Similarly, the heart muscle cells that are 
affected stop contracting and the overall heart function deteriorates. Molecular imaging 
excels at detecting the cellular changes that occur early in the course of a disease, often well 
before structural changes can be seen with other diagnostic imaging resources such as CT 
and MRI. Most molecular imaging procedures involve an imaging device and an imaging 
agent. A variety of imaging agents are used to visualize cellular activity, such as the chemical 
processes involved in metabolism, oxygen use or blood flow. In nuclear medicine, which is a 
branch of molecular imaging, the imaging agent is a radiotracer, a compound that includes a 
radioactive atom and a specific imaging agent. Other molecular imaging modalities, such as 
optical imaging and molecular ultrasound use a variety of different agents. Once the imaging 
agent is introduced into the body, it accumulates in a target organ or attaches to specific cells 
depending on the substance injected. The imaging device detects the radiation (and thus the 
amount and localization) of the radiotracer and creates images that show how it is distributed 
in the body. Depending on the process, different images are created. This distribution pattern 
helps physicians discern how well organs and tissues are functioning [2–4].  
 
Nowadays, PET is always fused with the CT technique. The Radboud University MC uses 
Low Dose CT for fusing images. It is the fusion of functional (PET) and anatomic information 
(CT) acquired almost simultaneously that lets us see the body and disease in a way that is 
diagnostically more powerful than both imaging techniques separately. An understanding of 
the normal and benign as well as the pitfalls and artifacts is essential to accurate 
interpretation. 
The PET/CT scanners are essentially full ring coincidence detectors, the P.E.T. portion, 
physically mounted together with CT systems of various types. There are various PET 
crystals (BGO, LSO, GSO) used to detect the emission photons and convert them to light 
signals. This scintillation event is converted to an electric signal, matched with another 
coincidence signal, within the selected time window, and a line of response (LOR) is made. 
All LOR’s can be reconstructed to an image that can be displayed on a monitor. 
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Photons that originate from structures deeper in the body are more highly attenuated by the 
intervening soft tissue than those originating closer to the surface. This effect of attenuation 
is not accounted for in the non-attenuation corrected images, which appear to have high 
activity towards the surface of the patient and relatively low activity toward the centre.  
In addition to providing anatomic data, the low dose CT is scaled down and used as a 
transmission scan to generate an attenuation map that can be used to correct this 
attenuation effect. Because of the lower photon energy of the CT x-rays (polychromatic 100-
140 keV), the CT attenuation coefficients are rescaled to reflect the attenuation of the high-
energy monochromatic 511keV emission photons. Then, the energy-scaled CT is scaled 
down in resolution (matrix) to correct for the high spatial resolution of the CT in comparison 
to the PET. Once fully scaled, the CT can be applied to the emission (uncorrected) data to 
obtain the attenuation corrected PET image.  
This correction process is essential for quantitative assessment (S.U.V. standardized uptake 
values) as well as improved image quality. Since artifacts can be introduced during this 
process, any suspected findings can be verified by seeing if the abnormality was present on 
the uncorrected emission image [2,3,6]. If it is present on the uncorrected image, then it is 
likely an increased uptake took place. For example, a patient with a high density hip 
prosthesis will overcorrect the PET scan in that area. Similar artifacts occur when the patient 
moves between CT acquisition and PET acquisition (e.g. breathing). 
Usually the CT transmission scan is acquired followed by the PET scan. Because the 
scanners are in the same gantry the patient remains in the same position on a single 
scanning table scans. Therefore they are intrinsically registered as seen on the fusion image.  
 
 
 
Illustration 2 - Example of PET/CT scanner 
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18F-Fluorodeoxyglucose 
 
Since the patients went through PET/CT scans with this specific radiopharmaceutical, it is 
important to know the main principles behind it. 
PET/CT radiopharmaceuticals are different from the ones used in gamma cameras as they 
have radionuclides that are positron emitters and the majority of them have very short half-
lives. Today, more than 95% of PET procedures worldwide are performed with F-18 fluoro-
deoxyglucose (FDG) [11,12]. This situation is due to practical reasons: Fluorine 18 is easily 
produced by cyclotrons, with the capability to radiolabel relevant biological molecules. 
Because of the relatively long half-life (110 minutes) with respect to other positron emitters 
such as shorter lived C-11 (20.4 minutes), N-13 (10 minutes) and O-15 (2 minutes), Fluorine-
18 is the only one in this series that can be distributed also to PET/CT centres without 
cyclotrons. Therefore it can be used in a wider geographic area [11]. From a chemical point 
of view, Fluorine is part of a group in the periodic table called halogen, allowing a very stable 
binding that does not affect the functional part of the molecule. But the real “absolute” value 
of F-18 is derived by its capability to radiolabel deoxy-glucose producing FDG; i. e., the 
glucose analogue.  
Glucose is an essential compound for living organisms, being the most important carbon 
supplier with most metabolic processes depending largely on its availability. The slightly 
adapted version called deoxyglucose has the property that it is taken up by cells like normal 
glucose, but cells are not capable of metabolizing it further, therefore (fluor)deoxyglucose 
accumulates in the cells and is not exhaled as H2O and CO2 as normal glucose would be. 
 
Pathophysiology of Glucose and FDG’s Biodistribution 
 
To correctly interpret PET/CT images, based on the interpretation of all molecular involved 
events, first we need to analyse the normal glucose distribution, starting from the knowledge 
of its pathophysiological behaviour. A more extensive and/or specialized publications based 
on a deeper analysis of FDG as a “molecular tracer” of glucose transporters, suggests that 
glucose uptake in human cells can take place through two mechanisms: facilitated diffusion 
and active transport [11,12]. The first one is a carrier-mediated transport, therefore 
characterized by saturation (and influenced by insulin, increasing its rate up to 20-fold). This 
means that a competitive inhibition of transport can occur in the presence of a second ligand 
that binds to the same carrier. This also explains the strong interference on FDG uptake 
determined by variations in glucose and insulin levels in the blood and by diabetes. High 
levels of insulin will force FDG, along with glucose, into skeletal muscle, myocardium and 
Masters in Nuclear Science Applied to Health, ESTESC 
The effects of weight and injected dose in the liver’s Signal-to-Noise Ratio in patients submitted to PET/CT scans 
Diogo Teixeira da Silva Duarte  13 
 
liver, increasing the image background and decreasing the availability of the tracer for uptake 
by the lesions not influenced by insulin. For these reasons, it is crucial to define a fasting 
time (at least 4–6 hours), a serum glucose range (3-7 mmol/L, below 10 mmol/L) and, in 
diabetes, the timing after insulin injection (4 hours prior to the scan). High glucose values or 
when there’s presence of insulin, reduces diagnostic accuracy because of their strong 
interference with the biodistribution [11].  
 
FDG “Trapping” 
 
After glucose has been taken up in the cells by the membrane-bound sodium dependent 
glucose transporters (GLUTs), the biochemical destinations of glucose start with 
phosphorylation. The phosphorylation, both for glucose and FDG, is promoted by hexokinase 
in the large majority of cells, being dependent on glucokinase in the liver [11]. After this first 
step, glucose-6-phosphate progresses in its metabolic destination, undergoing further 
glycolysis with as ultimate products: energy, H2O and CO2. Glucose-6-phosphate can also be 
dephosphorylated mediated by glucose-6-phosphatase (gluconeogenesis) used for the 
storage of glycogen. FDG-6-phosphate can’t be further metabolized in the glycolytic 
pathway, as this molecule will not fit in the hexokinase enzyme. Therefore, it remains 
“intracellularly trapped”, because of the lack of significant amounts of FDG-6-phosphatase to 
reverse the phosphorylation. This is a major advantage for PET/CT imaging: the “trapped” 
FDG can reliably “in vivo” trace glucose’s fate, reflecting the glucose metabolism in the whole 
organism. Healthy individuals do not excrete glucose through the urinary system but an 
intense FDG uptake is observed in the urinary system. In fact, whereas normal glucose is 
freely filtered by glomeruli and rapidly reabsorbed by the nephron, FDG is poorly reabsorbed 
after filtration, being excreted in a large amount in the urine. In individuals with normal renal 
function, 50% of the radioactivity reaches the bladder in two hours [11]. A way to reduce the 
dose to the urinary system is maintaining a good hydration and frequent toilet use, under the 
influence of forced diuresis by furosemide.  
A major contraindication, which has to be remembered, is that FDG crosses the placenta, 
being distributed mainly in fetal brains and excreted by fetal kidneys. However, the 511 keV 
radiation occurring from positron annihilation in the mother would contribute to the major 
radiation burden of the developing fetus. 
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Physiological and Para-Physiological Distribution of FDG 
 
After fasting for at least 4-6 hours but well hydrated, the patient is injected i.v. with FDG 
before the PET/CT scan. During the injection and the following uptake phase of one hour 
preceding the scan, the individual has to rest in a quiet room, comfortable, warm and 
relaxed. The patient must try to avoid muscular or regional cerebral activity because this will 
increase FDG uptake in those areas. Since it is impossible to avoid breathing and/or 
swallowing, the glucose uptake can’t be controlled in this case. Patients undergoing a 
PET/CT scan for head and neck tumours have FDG uptake in the vocal cords when talking.  
Under standard conditions the highest FDG activity is seen at the cerebral level (mainly in 
grey matter), since the brain is the only organ exclusively using glucose as a metabolic 
agent. When fasting, cardiac uptake is variable, but most commonly has a mild and 
homogeneous uptake but this can be very heterogeneous as parts of the myocardium can 
use fatty acids for fuel as well. Sometimes it can be hard to analyse the heart due to high 
blood pool activity at the level of the great vessels, mainly in the mediastinum. While liver 
and spleen show high and low-grade diffuse activity respectively, variable uptake is seen in 
the gastrointestinal system, creating difficulties in the analysis and problems in differential 
diagnosis in the guts. Low and/or absent concentration of FDG is observed at the level of 
bone marrow. No activity is also seen at the level of normal lymph nodes, but after FDG’s 
extravasation at the injection site, high uptake in the draining regional glands can be seen. 
Moderate activity can be seen in tonsils, salivary glands, myelohyoid muscles and, in young 
patients, in the thymus, adenoidal tissue and testicles. No uptake is normally seen at the 
level of lungs. The skeletal muscle’s uptake increases as a specific response to stress and/or 
exercise in the involved muscular cells. An increased uptake can be determined by many 
conditions such as hyperventilation, hiccupping, torticollis and intense eye movement, as a 
result of (in)voluntary tensions. The muscular uptake is generally bilateral and symmetric. An 
apparent unilateral pathological concentration can be observed contra laterally to a nerve 
palsy. The urinary excretion, determining a high normal background at the renal and vesicle 
level, can create difficulties in evaluating FDG’s pathological uptake in the pelvic area. Small 
areas of ureteric stasis may simulate lymphadenopathy. The presence of different locations 
of kidneys and ureters has to be known to avoid mistakes in PET/CT images interpretation. 
Diffuse thyroid uptake can be occasionally observed in clinically normal patients, being 
frequently caused by thyroiditis or hyperthyroidism. In premenopausal women (and/or in 
women taking estrogens) breast tissue often demonstrates moderate symmetrical FDG 
concentration. Breastfeeding mothers present intense uptake. A faint-to moderate uterine 
uptake can be observed during menstruation. In adipose tissue a typical symmetric intense 
uptake can be determined by active brown fat, mainly in winter months in young patients with 
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a lower body mass index. Since the lesion’s detectability in nuclear medicine is dependent on 
lesion/background ratio, it is evident that major difficulties in PET/CT are present at the 
cerebral level and/or in the abdominal-pelvic territory. Nevertheless, many physiological and 
para-physiological uptakes can be distinguished by the morphostructural information 
obtained by CT.  
 
 
 
Illustration 3 - Examples of normal FDG uptake 
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Normal FDG uptake in the liver 
 
At the time of imaging, (approximately 1 hour after injection) moderate uptake can be seen 
throughout the liver in almost all patients [5,7,13]. The level of uptake is usually slightly 
higher than blood pool activity. The distribution sometimes can be somewhat heterogeneous 
and difficult to interpret but generally the liver shows a homogenous distribution [5,7]. This 
problem is further affected by artifacts as a result of attenuation correction methods and 
movement during breathing. For example, the positioning of the arms can influence the 
quality of the image in the liver area. Sensitivity for the detection of small benign hepatic 
lesions is low in the liver due to small FDG uptake in a moderate FDG uptake organ. This 
can make diagnosis difficult for physicians. However, there is an increased FDG uptake in 
tumour cells due to increased expression of glucose transporter (GLUT) molecules on the 
cell surface, increased activity of hexokinase and reduced levels of glucose-6-phosphatase.  
 
 
 
Illustration 4 - Normal liver uptake (left) and abnormal liver uptake (right) 
 
 
 
The liver is a major organ for carbohydrate metabolism and storage. It is particularly involved 
in glycolysis and glycogen storage. Hepatocytes have high levels of glucose-6-phosphatase, 
which allow for intracellular FDG clearance from the liver. This decreasing activity is beyond 
what is expected simply due to decay of the radionuclide but under usual circumstances is 
very small (phosphorylation rates are 100 to 1000x higher than dephosphorylation rates). 
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Body Mass Index 
 
In order to relate the Signal-to-Noise Ratio of the liver with the patient’s weight, it’s important 
to have a measurement tool that relates the weight with the height. By only using weight, we 
don’t take in consideration the height, which means the patient can be heavy and 
theoretically is considered obese but the real weight category might not be the same. Among 
every tool available for this calculation, Body Mass Index (BMI) seems to be the most 
appropriate one. Body Mass Index is a number calculated mainly from a person's weight and 
height, although age and gender can also be considered. BMI is a fairly reliable indicator of 
body fatness. BMI can be considered as an alternative for measuring body fat. Additionally, 
BMI is an inexpensive and easy-to-perform method of screening for weight categories [14–
16]. 
 
However, it is important to remember, that BMI is not a direct measure of body fatness and 
that BMI is calculated from an individual's weight, which includes both muscle and fat. As a 
result, some individuals may have a high BMI but not have a high percentage of body fat. For 
example, highly trained athletes may have a high BMI because of increased muscularity 
rather than increased body fatness. Although some people with a BMI in the overweight 
range (from 25.0 to 29.9) may not have excess body fatness, most people with a BMI in the 
obese range (equal to or greater than 30) will have increased levels of body fatness. The 
standard weight status categories associated with BMI ranges for adults are shown in the 
following table [14].  
 
 
BMI Weight Status 
Below 18.5 Underweight 
18.5 – 24.9 Normal 
25.0 – 29.9 Overweight 
30.0 and Above Obese 
Table 1 - BMI Categories 
 
 
Although it has its limitations, most patients that were collected are considered to be “normal” 
relatively to their weight, making this tool the best one to make the calculations. BMI is used 
as a screening tool to identify possible weight problems for adults but is not considered a 
diagnostic tool [14].  
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BMI is calculated the same way for both adults and children. The calculation is based on the 
following formula: 
 
2(m)] [Height
(Kg) Weight
 
 
 
 
The correlation between the BMI number and body fatness is fairly strong; however the 
correlation varies by sex, race, and age. These variations include the following examples: 
 
• At the same BMI, women tend to have more body fat than men. 
• At the same BMI, older people, on average, tend to have more body fat than younger 
adults. 
• Highly trained athletes may have a high BMI because of increased muscularity rather 
than increased body fatness 
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Procedure 
 
The purpose of this project is to study and analyse the effects of the patient’s weight on the 
Signal-to-Noise Ratio (SNR) in the liver. The first objective is to see if there is any relation 
between the dose injected, the SNR and the weight. The Body Mass Index was also 
calculated for each patient, taking in consideration his or her age, height, weight and gender, 
according to the National Health Service from the United Kingdom. This calculator was used 
because it takes in consideration a lot of variables and the study must be as precise as 
possible. This variable was also used to also see if there is a relation with the dose injected 
and the SNR but it became clear that BMI isn’t useful in clinical practice. The second 
objective of this project is to try to get to a new formula to calculate the new FDG dose and 
get a better and constant SNR without being affected by the patient’s bodyweight. 
 
The project started by selecting patients with different weights from the department’s 
database. 65 patients (39 males and 26 females) with weight ranging from 39 Kg to 125 Kg 
and BMI ranging from 14,5 to 39,45 were gathered, retrospectively. All the selected patients 
were scans performed in the department in several different periods of time, in a standard 
protocol (4 minutes per bed position) on the specific model Siemens Biograph mCT. The 
dose given to these patients was calculated with the following formula, based on the 
Netherlands protocol for standardization of FDG whole body PET studies (NEDPAS 
Protocol) [17] and on scanner properties: 
 
MBq  
position bed per Minutes
Kg) in Weight(6,4×
 
 
Several exclusion criteria were used for the selection of the patients:  
 
• If the patient had diabetes, it couldn’t be selected because it would affect the FDG 
uptake and would affect the outcome results; 
• Any kind of liver disease (including metastases) that would affect the assumption of 
homogeneous distribution of FDG uptake; 
• Any kind of breathing artifacts that would affect the liver and if another portion of the 
organ couldn’t be selected; 
• Any kind of disease that would affect the FDG normal distribution on the body; 
• Any surgical history on the liver that might affect the SNR; 
• Any changes performed in the scanning protocol, like arms down; 
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After the selection of the patients, the SNR was going to be calculated in every person. The 
SNR was used as a measure of the quality of the PET/CT images and was analysed as a 
function of the patient’s body mass. This measure was calculated for each patient in the liver, 
because it is the only large organ in the human body that has a relatively homogeneous 
distribution of FDG uptake. In the software “Hermes”, with the help of a crosshair, five slices 
were selected and the SNR was determined on each one of them, using the same sized 
Region of Interest (ROI). The selected slices were chosen at a position where the cross-
section area of the liver was at maximum. The mean signal (MBq/Kg liver tissue) and the 
standard deviation (SD, MBq/Kg liver tissue) [18] were measured in the selected area of the 
liver. As we assume the liver is an organ with homogenous glucose metabolism [5,7,19], the 
mean uptake reflects the image signal and standard deviation reflects the image noise. This 
took in consideration possible artifacts like partial volume effect, so the slices were selected 
away from the boundaries of the liver or other intrahepatic structures like vessels or gall 
bladder. With both of these values, the SNR was calculated by dividing the mean signal with 
the standard deviation. For each patient the mean SNR was determined five times to make 
sure that a reliable value was obtained. 
There are two different PET images: PET Whole Body (WB) and PET WB European 
Association of Nuclear Medicine (EANM). The main differences between these two are in the 
parameters of Image Size and the Full Width at Half Maximum (FWHM). In the PET WB, 
image size is 200 and the FWHM is 3.0 mm whilst in the EANM is 256 and 8.0 mm 
respectively. The FWHM is a parameter used to describe the point spread function of a 
source measured at half of its maximum shown on a curve or function. The lower this value 
is, the greater the spatial resolution will be. In other words, the PET WB has higher spatial 
resolution but therefore is noisier (less counts per pixel); the PET EANM has lower spatial 
resolution (i.e. is “smoothed”) and is therefore less noisy. Higher SNRs are therefore 
expected in the PET EANM than in the PET WB, but the relation with bodyweight is not 
expected to be different. 
After choosing the patient and the corresponding Computed Tomography Low Dose (CT-
LD), the PET WB and the PET, taking in consideration every view (transaxial, sagital and 
coronal), an optimal position was chosen in the liver. This was done on the CT image since it 
has a better image for localization and confirmed in the other images. By doing so, the 
position was automatically chosen in the other two PET images.  
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Illustration 5 - Positioning of the point in the CT scan 
 
 
Illustration 6 - Positioning of the point in the PET WB scan 
 
 
Illustration 7 - Positioning of the point in the PET WB EANM scan 
 
 
After choosing one point in the liver, a ROI would be made in five consecutive slices in the 
PET images. Every ROI was a circle with a diameter of exactly 50 mm. Since the CT was 
acquired with more slices than the PET, the slices made weren’t consecutive in the CT but 
intercalated. On the CT will appear that way but in the PET’s they are consecutive. 
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Illustration 8 - First ROI on CT (left), PET WB (middle) and PET WB EANM (right) 
 
 
   
Illustration 9 - Second ROI on CT (left), PET WB (middle) and PET WB EANM (right) 
 
 
   
Illustration 10 - Third ROI on CT (left), PET WB (middle) and PET WB EANM (right) 
 
 
   
Illustration 11 - Fourth ROI on CT (left), PET WB (middle) and PET WB EANM (right) 
 
 
   
Illustration 12 - Fifth ROI on CT (left), PET WB (middle) and PET WB EANM (right) 
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After making five ROI’s, we would get several values from that area of the five slices and 
three images. The values that are important for us are the “Mean” and the “Deviation”. Like 
reported earlier, the division between the mean and deviation would give the SNR. With the 
help of a table in Microsoft Excel, it was possible to automatically calculate the SNR of each 
slice and the mean SNR of every patient, by summing the five means and the five deviations 
and then dividing by five. This would give the mean of each value, which afterwards was 
used to calculate the SNR. This was done in both PET images. 
 
 
 
 
Illustration 13 - Values of the ROI's in the PET WB 
 
 
 
 
Illustration 14 - Values of the ROI's in the PET WB 
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Illustration 15 - Table of every value of every patient of PET WB 
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Results and Discussion 
 
After filling in all the values in the table about mean, deviation, SNR, dose injected (in MBq), 
gender, weight (in Kg), height (in cm) and BMI, several graphs related to SNR, dose, weight 
and BMI were made to see which were the results. All the graphs were made with the values 
of the PET WB and the PET WB EANM to see if there are any significant differences 
between them. 
 
  
Graphs 1 - Relation between Weight and Dose Injected on the PET WB (left) and PET WB EANM (right) 
  
 
First of all, relating the weight to the dose injected, we can see that both graphs look-a-like. 
The positioning of the points is quite similar and the behaviour of the graph is the same. So, 
as we can see, as the weight increases, the injected dose also increases, almost in a straight 
line. This makes sense, since the dose injected is dependent of the value of the weight in the 
formula used to calculate the dose. The points create almost an exact growing line. The 
function of the line is WeightDose ×= 62,1 . Therefore the patients are dosed 1.62MBq/kg 
which is exactly what we opt to give ( 6,1
4
4,6
= ). 
 
  
Graphs 2 - Relation between BMI and Dose Injected on the PET WB (left) and PET WB EANM (right) 
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Next, we have the graphs relating BMI to the dose injected. Like the previous one, both 
graphs have the same behaviours. And, like the previous graphs, the dose also increases as 
the BMI increases. However, it’s not the same increase as the weight in the previous graphs. 
This is because the dose is calculated in a formula that includes weight and not BMI. This 
measurement takes in consideration more values, so it is normal that the increase is not as 
concentrated as the previous ones. 
 
 
  
Graphs 3 - Relation between Dose Injected and SNR on the PET WB (left) and PET WB EANM (right) 
  
 
Comparing the dose injected with the SNR, we can see that both graphs have a similar 
behaviour. However, the PET WB EANM has higher SNR values due to the parameters 
reported earlier, which would give a smoother image and consequently increases the SNR 
values. As the dose injected increases, the SNR decreases. This is because patients who 
receive higher doses (at least in this study) are heavier and, as it was reported, as the weight 
increases, the dose would also increase. In other words: even though the dose in heavier 
patients is higher, the SNR still deteriorates. 
 
 
  
Graphs 4 - Relation between BMI and SNR on the PET WB (left) and PET WB EANM (right) 
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Like the previous graphs, both have a similar behaviour and only differentiate in the SNR 
values, due to the different parameters. So, comparing the BMI with the SNR, we see that as 
BMI increases, the SNR decreases. So, as the patient is considered more obese, the less 
quality the picture will have while patients who are underweight have a higher SNR. 
However, the quality seems to be best when the patient is considered normal weight 
(between the BMI values 19 to 24 approximately). 
 
  
Graphs 5 - Relation between Weight and SNR on the PET WB (left) and PET WB EANM (right) 
  
 
In these graphs, we can clearly see that as the weight increases, the SNR will decrease 
(even though higher FDG doses are given) in both PET WB scan and the PET WB EANM 
scan. When the patient is light, the SNR is higher and so the quality of the image will be 
better. 
 
There are some interesting findings in these graphs. With these results, it can be said that 
the weight does interfere with the quality of the image, specifically the SNR. As we can see in 
Graphs 5, when the patient is heavier, the SNR clearly decreases. Graphs 4 shows that the 
SNR also decreases with BMI. So, as the patient is considered more obese, the quality of the 
image is decreased. So, obesity indeed affects image quality due to the photon attenuation 
and scatter fractions being higher in obese patients than in patients with a normal BMI or 
weight. The dose injected increases as the weight and BMI increase, as it should according 
to the formula to obtain the optimal dose, according to the department’s protocol. However, 
according to the findings in Graphs 3, following this formula, the heavier patients don’t have 
the same SNR as thinner patients. The behavior of the Graphs 3 and 5 should be almost an 
horizontal line because we want a constant SNR in all patients and not a decrease with 
patients’ weight. 
 
So, with these results, it was shown that the formula used to calculate the optimal dose for 
patients performing PET/CT scans isn’t the best one for a constant SNR, regardless of the 
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patients’ weight. Taking this in consideration, a new formula was needed in order to get a 
constant SNR for all patients. 
 
Starting from the beginning, the current FDG dose is calculated with the following formula: 
 
WaD ×=  
Equation 1 
 
The Dose D is a value in MBq, the a is the value used to calculate the quantity of MBq per 
Kilogram (MBq/Kg) and the W is the weight of the patient. The a value is 1,6MBq/Kg 
(i.e.
4
4,6
). In order to check if the data collected is correct, we can confirm this value with the 
following graphic: 
 
 
Graphic 6 - Linear line for weight and dose injected 
 
Based on the study of 65 patients (weight ranging between 39 to 125 kg, with the median 
being 86 kg), the injected dose was, in fact, 1,62MBq/kg (R2=0,96), therefore the patients 
were indeed injected with the dose according to protocol. 
The quality of a PET/CT scan was defined in this project as Signal-to-Noise Ratio and, as 
reported earlier, it can be calculated by dividing the mean liver activity concentration (µ ) by 
the standard deviation of activity concentration in the liver (σ ): 
 
SNRliver =
µliver
σ liver
 
Equation 2 
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We can assume that there is a relation between the number of detected true events (Tliver 
[counts/mL]), µliver and σliver. According to Poisson statistics, the following could be expected 
(n=0,5 if Poisson statistics are considered) [18]: 
 
µliver ∝Tliver  
Equation 3.1 
 
σ liver ∝ (Tliver )n  
Equation 3.2 
 
 
There’s a relation between Tliver and the dose injected (DA [Bq]) which is dependent on the 
activity concentration of the radiopharmaceutical in the liver (ACliver [Bq/mL] dependent on 
biodistribution of the pharmacon and its pharmacokinetics) and on the relation between 
detected true events and total events (e.g. photon scattering, photo attenuation correction, 
etc). These factors are supposed to be dependent on the size of the patient [F(X) with X 
being the variable to describe the patient size (weight or BMI)]: 
 
Tliver ∝DA ×F(X)  
Equation 3.3 
 
 
From this equation, we can obtain the following: 
 
µliver ∝DA ×F(X)  
Equation 3.4 
 
σ liver ∝ (DA ×F(X))n  
Equation 3.5 
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SNRliver ∝
µliver
σ liver
∝ (DA )1−n ×F(X)1−n  
Equation 3.6 
 
 
The measured SNRliver should be normalized for (DA)1-n to describe the weight dependent 
quality function F(X). This is defined as the case that every patient of any weight would have 
received DA=1 Bq and is hereby called the normalized SNRliver denoted by asterix: 
 
SNR*liver ∝
SNRliver
(DA )1−n  
Equation 4 
 
 
There’s an inverse relation between SNR*liver and measure for patient size, defined by X 
(weight or BMI): the lower the SNR*liver is, the higher the X is. 
This kind of relation can be of three kinds: linear, power or exponential. Since the relation is 
expected to be negative, r1 is expected to be lower than 0 in any type of regression: 
 
Linear: 
SNR*liver = r1 × X × r2  
Equation 5a 
 
Power: 
SNR*liver = r2 × Xr1  
Equation 5b 
 
Exponential: 
SNR*liver = r2 × er1×X  
Equation 5c 
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Since the current adopted formula has proven to be insufficient (equation 1), we want a new 
relation between target dose (DT) and body size (X). This new relation (D’T (X)) would lead 
to a constant SNRliver whose value is dependent on the needs of the physicians and is called 
SNRstandard. 
Based on equation 4, we can have derive: 
 
SNR*liver =
SNRstandard
(D 'T (X))1−n
 
Equation 6a 
 
Therefore: 
 
D 'T (X) =
SNRstandard
SNR*liver
!
"
#
$
%
&
1
1−n
 
Equation 6b 
 
 
The SNRstandard is a value determined by physicians based on what they describe as 
minimal image quality. This can be expressed as function of body size: 
 
 
SNRstandard = SNRliver (X) = (DA )1−n ×F(X)1−n  
Equation 7 
 
 
So, for example, if the physician considers a scan of a 86 kg patient (b) with the current 
dosing formula the minimum image quality that should be attained in patients of any body 
size, we can consider the following: X = W; W = b = 86; DA = DT = a x W = a x b.  
In this case, we have: SNRstandard = (a×b)1−n ×F(X)1−n . 
 
Replacing equations 1, 5a, 5b and 5c, results in: 
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Linear: 
D 'T (X) = a×b×
r1,W ×b+ r2,W
r1,X × X + r2,X
"
#
$$
%
&
''
1
1−n
 
Equation 8a 
 
 
Power: 
D 'T (X) = a×b× r2,W( )
1
1−n ×b
r1
1−n × (r2,X )
−
1
1−n × X
−
r1
1−n
 
Equation 8b 
 
 
Exponential: 
D 'T (X) = a×b× r2,W( )
1
1−n × e
r1
1−n×b × (r2,X )
−
1
1−n × e
−
r1
1−n×X
 
Equation 8c 
 
 
These three equations can be simplified to: 
 
Linear: 
 
D 'T (X) =C1 ×
C2
r1,X × X + r2,X
"
#
$$
%
&
''
1
1−n
 
Equation 9a 
 
With C1 = a×b∧C2 = r1,W ×b+ r2,W  
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Power: 
 
D 'T (X) =C3 × XC4  
Equation 9b 
 
With C3 = a×b× r2,W( )
1
1−n ×b
r1
1−n × (r2,X )
−
1
1−n ∧C4 = −
r1
1− n  
 
Exponential: 
 
D 'T (X) =C5 × eC6×X  
Equation 9c 
 
With C5 = a×b× r2,W( )
1
1−n × e
r1
1−n×b × (r2,X )
−
1
1−n ∧C6 = −
r1
1− n  
 
 
In order to check if the Poisson assumptions were correct, a Ge-68/Ga-68 cylindrical 
phantom (V=8407 mL, Activity Concentration = 5,768 Bq/mL at time of acquisition) was 
scanned for 60 minutes in listmode together with a CT-LD using clinical settings. This data 
was histogrammed for different time intervals, from 5 seconds up to 3600 seconds, to 
represent different activity concentrations. Based on the total amount of Ga-68 events 
(decays/mL) occurring during these timeframes, the corresponding activity concentration of 
F-18 (Bq/mL) was computed for a hypothetical scan of 4 minutes acquiring the same amount 
of F-18 events. 
From previous scans, we have acknowledged that the mean liver SUV’s vary from 1.4 to 5.6 
g/mL (mean 2.6) with an injected dose of 1.6MBq/Kg. This means that a liver has an activity 
concentration from 2.2 to 9.0KBq/mL (mean 4.1). 
For the range of extreme low dosing (around 0.5MBq/Kg) and extreme high dosing (around 
4MBq/Kg), this would lead to an activity concentration of the liver between 0.7kBq/mL and 
22.5kBq/mL, corresponding to a number of G-68 decays acquired during a time-frame 
between 30 and 900 seconds. From this, n≈0,488 (all data, 95%-CI: [0,482-0,494]) and 1-
n≈0,493, resulting in n≈0,507 (within the range of 30-900s, 95%-CI: [0,485-0,501]) so the 
Poisson relation assumption is nearly correct. 
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Framelength (s) 
Total Ga-68 
(decays/mL) 
Similar F-18 AC 
(Bq/mL) 
SNR 
5 28841 124 1,9 
10 57681 249 2,6 
15 86522 373 3,2 
30 173044 746 4,6 
60 346088 1491 6,4 
90 519132 2237 7,9 
120 692175 2983 9,1 
180 1038262 4474 11,1 
240 1384348 5965 12,9 
300 1730433 7457 14,2 
360 2076518 8948 15,7 
420 2422602 10439 16,9 
480 2768686 11931 18,1 
540 3114769 13422 19,1 
600 3460851 14913 20,2 
900 5191254 22370 24,3 
1800 10382369 44739 33,6 
2700 15573346 67107 39,7 
3600 20764185 89475 44,7 
Table 2 - Relation between liver's AC and SNR based on measurements on a Ga-86/Ge-68 phantom 
 
 
  
Graphs 7 - Relation between SNR and ACliver from 5 to 3600s and 30 to 900s respectively 
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Based on the 65 analised patients (with the median being 86 kg in a range between 39 and 
125 kg), the injected dose was 1,62MBq/kg (R2=0,96). The different correlation coefficient for 
the relation between SNR*liver and X are: 
 
 Clinical Reconstruction EANM Reconstruction 
Linear r1 r2 R2 r1 r2 R2 
X=W -0,008 1,241 0,774 -0,017 2,654 0,724 
X=BMI -0,025 1,264 0,621 -0,053 2,671 0,555 
Power r1 r2 R2 r1 r2 R2 
X=W -0,932 34,126 0,777 -0,967 83,137 0,726 
X=BMI -1,020 15,957 0,639 -1,031 34,587 0,566 
Exponential r1 r2 R2 r1 r2 R2 
X=W -0,013 1,620 0,790 -0,013 3,549 0,749 
X=BMI -0,040 1,669 0,626 -0,041 3,532 0,555 
Table 3 - Regressors (r1 and r2) and fit quality (R2) between SNR*liver and different measures of body size 
(W and BMI) 
 
From the table above, we can see that r1<0 and the highest correlations (R2) were reached 
for weight as measure for body size (X=W), therefore BMI was not considered any further. 
There is only a slight preference for exponential regression over power and linear regression. 
For X=W we have the following: 
 
 
Illustration 16 - Relation between weight and SNR*liver in Clinical and EANM reconstructions 
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The SNR is clearly higher in the EANM reconstructions, due to the different parameters 
resulting in lower noise levels. A linear relationship is unlikely since it will reach negative 
values, which is not possible. For both the power and exponential regression, negative 
values will not be reached. 
Therefore, linear equation was not conisdered and equations 9b and 9c, using X=W will take 
the following form: 
 
D 'T (X) =C3 ×WC4  
Equation 10b 
 
With C3 = a×b×
r1
1−n+1
#
$
%
&
'
(
∧C4 = −
r1
1− n  
 
D 'T (X) =C5 × eC6×W  
Equation 10c 
 
With C5 = a×b× e
r1
1−n×b
#
$
%
&
'
(
∧C6 = −
r1
1− n  
 
For the hypothetical case based on clinical image reconstruction with X=W, a=1,6 MBq/kg 
and b=86 kg (median bodyweight), we can derive the following new dosing formulas: 
 
Power 
D 'T (W )[MBq]= 0,0305×W[kg]1,889
SNR*liver = 0,537
SNRstandard = 6,1
 
Equation 11b 
 
Exponential: 
D 'T (W )[MBq]=15, 41× e0,02546×W [kg]
SNR*liver = 0,550
SNRstandard = 6,2
 
Equation 11c 
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Therefore, in order to have a bodyweight independent SNRliver of 6,1-6,2, corresponding to a 
scan of a 86 kg with the current dosing formula, the new dose to be administered should be 
according to equation 11b or 11c. 
Now that we have a new formula to calculate the dose of FDG to be injected, we can 
simulate how this new dose will affect the SNR. Using Equations 4, 6a, 11b and 11c we can 
obtain these values. After inserting the equations in Excel, we got the results of the new dose 
(D’T(X)), the SNR*liver and the new SNR in the liver (SNRstandard). Now, we can see if 
there’s a different behaviour regarding these new values. 
 
 
  
Graphs 8 - Relation between weight and New SNRliver based on Power and Exponential Formula 
  
Comparing these graphs with graphs 5, we can see a big difference now. While on graphs 5, 
the SNR would decrease as the weight increases, here we have a different behaviour. While 
with the old dosing formula, there was a big decrease in SNR, here we have a constant 
value, maintaining an acceptable one (around 6.1 in power formula and 6 in exponential). 
Between both formulas, the difference is not that big and the SNR is a matter of decimals 
only, not resulting in a very different image quality.  
The relation between weight and the SNR based on the new dose is somewhat negative. 
Analysing the regression lines ( y = −6−0,5x + 6,0927 for power and y = −0,0027x + 6,2352  for 
exponential), both of them state that there is a decrease in SNR per kg of weight. However, 
due to both values, this decrease is extremely low and almost irrelevant. 
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Graphs 9 - Relation between Weight and New Dose based on Power and Exponential Formula 
  
Comparing graphs 9 to graphs 1, we can see now that as the weight increases, the new 
dose increases exponentially instead of linearly. This means that lighter patients will receive 
less FDG dose and the heavier patients will receive more dose than with the previous 
dosage formula. This will achieve a more constant SNR instead of a decreasing one. 
 
  
Graphs 10 - Relation between new Dose and New SNRliver based on Power and Exponential Formula 
  
Comparing graphs 10 to graphs 3, there’s clearly a difference with this new formula. The 
SNR now maintains a constant value. Whereas in graphs 3 the SNR would decrease from 
around 9 to 4, in this case maintains a SNR value of around 6, in both formulas.  
We only presented both formulas in clinical reconstructions and not in EANM reconstructions 
because the behaviour would be exactly the same, only the SNR would be higher due to less 
noisier values.  
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Graphic 11 - Relation between the dose injected and the new dose based on Power Formula 
 
 
Graphic 12 - Relation between the dose injected and the new dose based on Exponential Formula 
 
In these graphs, we can see that as the weight increases, the dose increased, whether was 
calculated with the current formula or with the new ones. However, for patients lighter than 
86 kg, the dose injected is higher than the new dosing regimens with a significant difference. 
For patients heavier than 86kg (the reference mass b), we can see that the new doses are 
increasing exponentially. In the following table, we can see the different total quantity of FDG 
needed in our population using the new dosing formula compared to the current one and the 
total effective dose in adults (based on the value of 0,019 mSv/MBq): 
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Type of 
formula 
Total Injected 
Dose (MBq) 
Total New Doses 
(MBq) Difference 
Total effective 
doses in adults 
(mSv/MBq) 
Power 8618 8531 -87 162,089 
Exponential 8618 9047 429 171,893 
Table 4 - Difference between injected doses, new doses and total effective doses 
 
 
With these results, it’s possible to say that using the power formula, we would need less FDG 
to get a weight-independent SNR. But using the exponential formula, we would use more 
FDG as it is given with the current formula but still get a weight-independent SNR for all 
patients. However, the total injected dose is different from the calibrated dose, so this value 
might be less than it actually is. 
Using the same method as we did, vDalen et al [5], Wientjes et al [20] and de Groot et al 
[21], used a similar research and found the following: 
 
 
 vDalen et al. Wientjes et al. De Groot et al. This project 
Linear 
dosing: 
DT = 2,3×W  DT = 2,3×W  
DT = 5×W
< 90Kg
DT = 2,13×W
> 90Kg
DT =191, 7+ 5(W − 90)
 DT =1,6×W  
Standard 
SNR: 
6 
7,8 (75Kg 
patient, 4 
min/bp) 
9,58 6,1 (86Kg patient) 
New Dose 
(MBq): 
1, 46×10−3 ×W 2,66  3,6×10
−3
2, 5×W 2,146  0,023×W
2,047  
0,0305×W[kg]1,889
15, 41× e0,02546×W [kg]
 
Table 5 - Equations for non-linear dosing according to several references 
 
 
 
 
 
Masters in Nuclear Science Applied to Health, ESTESC 
The effects of weight and injected dose in the liver’s Signal-to-Noise Ratio in patients submitted to PET/CT scans 
Diogo Teixeira da Silva Duarte  41 
 
 
Graphically, looks like this: 
 
 
Graphic 13 - Equations for dosing schemes according to different references 
 
 
With all this considered, we should ask ourselves what is the ideal reference mass. For 
image quality, the lowest reference mass will be best (as lighter patients give better images). 
From a radiation point of view, a higher reference mass will be best [as all patients with a 
weight below the reference mass will get less FDG and all patients heavier will get 
(exponentially) more FDG] [22,23]. The latter is also the case from a financial point of view. 
The question therefore should be towards an acceptable SNR. This question can only be 
answered by nuclear medicine physicians. As an example, the following PET WB 
reconstructions are presented showing 5 extremes of SNR (highest SNR, 70kg patient, 86kg 
patient, 100kg patient, lowest SNR): 
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Illustration 17 - The highest SNR 
 
 
 
Illustration 18 - SNR of a 70 Kg Patient 
 
 
Illustration 19 - SNR of an 86 Kg Patient 
 
Weight: 46 Kg 
SNR: 8,90 
Injected dose: 77 MBq 
Glucose: 4,2 mmol/l 
Weight: 70 Kg 
SNR: 7,68 
Injected dose: 119 MBq 
Glucose: 6,4 mmol/l 
Weight: 86 Kg 
SNR: 6,15 
Injected dose: 138 MBq 
Glucose: 6,3 mmol/l 
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Illustration 20 - SNR of an 86 Kg Patient 
 
 
 
Illustration 21 - The lowest SNR 
 
 
So, as we can see in these illustrations, between the highest and the lowest SNR, there is a 
clear difference in image quality, best seen in the liver. With the current formula used to 
calculate the necessary dose, it’s clear that as the weight increases, the SNR decreases and 
that affects the image. Therefore, we built new formulas to give us a weight-independent 
SNR of a 86 kg reference patient. We can see here that Illustration 18 gives us the highest 
SNR of all three references and Illustration 20 gives us the lowest one. However, in order to 
maintain the SNR of a 70 kg patient (SNR around 7,6) for all patients, a lot more of FDG 
would have to be ordered and heavier patients would receive even more FDG. Since the 
median of our population was 86 kg, the SNR of a patient with that weight is acceptable and 
Weight: 100 Kg 
SNR: 5,57 
Injected dose: 167 MBq 
Glucose: 5,2 mmol/l 
Weight: 105 Kg 
SNR: 4,69 
Injected dose: 168 MBq 
Glucose: 5,7 mmol/l 
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better than the one obtained currently in heavier patients. If the median is used, half of the 
patients would receive less FDG and the other half would receive more.  
With all this considered, the SNR of a 86 kg patient seems to be the most possible and 
acceptable one, taking in consideration new image quality (good quality), new costs (hardly 
changed), new doses (acceptable even for overweight patients) and new radiation burden. 
We found a negative relation between image quality and bodyweight even though heavier 
patients received more FDG. Based on Poissonian (and confirmed with a phantom) we 
suggested new dosing schemes that should give a weight-independent SNR with good 
image quality and with no additional costs or radiation burden to the whole group. However, 
this should be prospectively validated next. 
 
This study had some limitations. To evaluate the image quality, only the SNR in the liver was 
used and it didn’t take in consideration the soft-tissue contrast. However, the primary 
objective of this study was to see the effects of the weight in the SNR of the liver and not the 
image quality as a whole. The use of five consecutive ROI’s in a lot of different patients can 
vary due to the anatomy of each one. For example, the size of the liver might affect the 
localization of the five ROI’s. As a marker of noise, the standard deviation might not be 
enough, although it’s used in several studies related to clinical imaging. Noise is described 
as the extent of the variation in radioactivity in an image of uniform uptake. But there are 
several factors that can contribute to the image noise [7]. Another type is the structured noise 
which is generated from the process of reconstruction. There weren’t a lot of patients heavier 
than 110 kg, which restrained a little bit the results on much heavier patients. All the 
calculations were based on theory and a few assumptions and weren’t put in practice, even 
though the predictions are very promising since the assumption of Poissonian relation might 
not be correct in a corrected PET image. However, according to other studes [18], the 
assumption of Poissonian in this case should be correct, therefore making reliable results. In 
Table 4, the differences between the doses were based on the injected one and not the 
calibrated one. This may give us different results, since the total dose that was bought should 
be higher than those values presented. In the same table, total effective dose was also 
calculated; however, it was based on the value of 0,019 mSv/MBq (which is for a 70 kg 
healthy adult) but since the weight increases, the absorbed doses will also increase, 
therefore the results might be different [10,22]. Giving the FDG dose based on a different 
formula might not be the only option to obtain a constant SNR. Performing longer scans 
might increase the SNR of heavier patients compared to now since the PET image is based 
only on true coincidence detection (random, scattered photons are removed from the image) 
[5,7,8]. Doubling the dose will double the total counts derived from patients, but the number 
of randoms will also go up by a factor of 4. So, the net counts used to reconstruct an image 
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will not go up exactly by a factor of 2 and in very high doses of FDG it might even go down. 
This will not happen if the patient is scanned longer, since scanning twice as long will leave 
us with twice as much total counts but also with twice as much randoms and scatter, 
therefore the net counts used to reconstruct an image will double. It might be better to scan 
longer than to increase FDG dose but it is hard to model since we should know the count 
rate statistics of each scan [5,7,8]. Also, due to the planning system and logistics, this is not 
done in the department. Another factor against longer scans is the patient’s movement, since 
adding more time to the scan, the probability of him moving is higher. 
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Conclusion 
 
With the findings of this study, it’s safe to assume that the weight has an important role in the 
quality of the PET/CT image using the current formula. The more heavy the patient is, the 
less SNR the image will have even when FDG doses are (linearly) adapted to patient weight. 
This was also true for BMI, which takes in consideration height as well. Adjusting techniques 
in some parameters, like attenuation correction or others to reduce random and scatter 
noise, might be helpful in overweight patients but isn’t the solution. It is important to know 
that adjusting these kind of parameters may give an image which seems smoother and with 
a bigger SNR but the lesion detection might be reduced. Also, every nuclear medicine 
department has their own protocols and logistics, so it might not be desirable to make 
changes in the protocols, like scanning longer for every patient. With this considered, two 
new formulas to calculate the FDG dose to give to the patient were proposed. These new 
ways to calculate the dose gives, theoretically, a weight-independent SNR for every patient 
based on the SNR of a 86 kg reference mass patient. With the given equations, we can 
replace the values with the ones from a patient with a SNR we want and have that for 
everyone. But, having the SNR of a 70 kg patient might not be very helpful because, even 
though the SNR is quite good, the dosage would be very high and that implies more costs 
and more radiation burden for all patients. So, with the patients of this study with a 
distribution of weight between 39 and 125 kg, the median was 86 kg. This means that half of 
the patients will have less dose and the other half will have more and gives us an acceptable 
SNR for every patient.  
So, in conclusion, patient’s weight is an important factor in these procedures, since it affects 
the SNR of the liver. Proceding with the new given formulas, replacing W with the patient’s 
weight, it will give the new dose to be injected which will give, theoretically, a constant SNR, 
with the weight not being a factor anymore in patient’s SNR. 
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I. Research Plan 
 
 
 
 
What to do: When is scheduled to be completed: Status 
Collect patients 25th January, 2013 Done 
Collect theory background 
about PET/CT 22
nd – 23rd November, 2012 Done 
Collect theory background 
about FDG 22
nd – 23rd November, 2012 Done 
Translation of the PET/CT 
protocol 29
th November, 2012 Done 
Write first sketches in the 
project with collected 
information 
6th December, 2012 Done 
Collect studied information 
about FDG uptake on patients 
with different weights 
7th December, 2012 Done 
Collect information about 
normal liver uptake 13
th December, 2012 Done 
Analyse the various 
measurements tools available 20
th December, 2012 Done 
Decide with one measurement 
tool and describe it 21
st December, 2012 Done 
Add more data to the project 
with new collected information 11
th January, 2013 Done 
Review all the information 
collected in the project 18
th January, 2013 Done 
Decide how many patients to 
use and begin to analyse each 
one 
8th February, 2013 Done 
With the help of Hermes, do a 
ROI on every patient and get 
SNR result 
12th February, 2013 Done 
Make several graphs regarding 
the relation between weight, 
dose and liver’s SNR 
20th February, 2013 Done 
Analyse results and get to a 
conclusion  22
nd February, 2013 Done 
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With collected results, describe 
my analysis in the project 25
th February, 2013 Done 
Analyse result and reflect 
about if there is a direct 
relation between dose, SNR 
and weight 
25th February, 2013 Done 
Write about limitations found in 
the research 26
th February, 2013 Done 
Meet with Dennis Vriens and 
discuss possible ways to 
calculate a new formula 
25th February to 29th February, 
2013 Done 
Calculate new dose, new SNR 
and analyse graphs 27
th February, 2013 Done 
Write and present a first draft 
of the project 1
st March, 2013 Done 
Write and present a second 
draft of the project 6
th March, 2013 Done 
Write and present the final 
project 14
th March, 2013 Done 
 
Masters in Nuclear Science Applied to Health, ESTESC 
The effects of weight and injected dose in the liver’s Signal-to-Noise Ratio in patients submitted to PET/CT scans 
Diogo Teixeira da Silva Duarte  52 
 
II. PET/CT Standard Protocol 
 
Principle:*
!
FDG!is!accumulated!in!tissues!with!a!high!degree!of!glycolysis.!This!mainly!concerns!neoplastic!tissues!
and!from!lesions!with!a!high!concentration!of!inflammatory!cells,!such!as!activated!macrophages!and!
granulocytes.! FDG! goes! to! the! cell! membrane! in! the! same! way! as! glucose! and! both! are!
phosphorylated! in! the! cell.! The! remaining! molecule! (FDG>6>Phosphate)! differs! from! glucose>6>
phosphate! to! a! point! that! the! next! enzymes! used! in! glycolysis! have! no! more! effect.! The! FDG>6>
Phosphate! gets! trapped! intracellularly! as! it! can’t! enter! glycolysis! unlike! glucose,! while! this! one!
continues!with!the!glycolysis.!The!desphosphorylation!of!FDG!is!slow!and!within!the!acquisition!time!
of!a!PET/CT!scan,!it!remains!present!in!the!cell.!!
Tumour!cells!are!highly!dependent!for!their!energy!from!glycolysis.!Since!glycolysis!ATP!provides!less!
than! the! normal! tumour! cycle,! this! means! that! tumour! cells,! in! contrast! to! normal! ones,! have! a!
bigger!uptake,!therefore!they!also!need!uptake!from!FDG.!FDG!uptake!in!activated!white!blood!cells!
((18)F>FDG>WBCs)!is!increased!making!infections!and!acute!or!chronic!inflammations!visible.!
!
Indication:*
!
• Suspicion!or!presence!of!malignancy!or!infection.!
!
Contraindications:*
!
• Pregnancy;!
• Severe!claustrophobia.!
!
Required*material:*
!
• Radiopharmaceutical:!F>18!fluodeoxyglucose;!
• Nuclide:!Fluor>18;!
• Dosage:!((6.4!x!body!weight)!/!(number!of!min!/!BP)!MBq;!
• Minimum!dose!in!children:!20!MBq;!
• Administration:!Intravenous.!
!
Material*needed*for*the*scan:*
!
• Venflon/butterfly!needle!with!three>way!stopcock!and!10!ml!NaCl!0.9%;!
• 10!mg!furosemide;!
• "Glucocard!Memory!2",!System!1!for!glucose!measurement;!
• On!indication:!bladder!catheter;!
• On!indication:!diazepam!(5!mg/tablet)!or!oxazepam!(10!mg/tablet).!
!
Information*needed*concerning*the*patient:*
!
• Indication;!
• Possible!known!tumour!localizations;!
• Nature!of!malignancy;!
• Relevant!patient!history;!
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• Relevant!results!from!other!imaging!studies!(especially!CT/MRI);!
• Completed!contrast!checklist;!
• Diabetes!mellitus!requiring!medication!(insulin/o.a.d.);!
• Height!and!weight;!
• Claustrophobia.!
!
!
Method:*
!
Administered*radiopharmaceutical:*
A!nuclear!medicine!assistant!injects!the!radiopharmaceutical!intravenously.!
!
Patient*preparation:*
• The!patient!should!be!fasting!at!least!6!hours!before!the!start!of!the!study!and!must!not!have!
had!any!kind!of!glucose;!
• The!patient!should!not!have!been!administered!with!insulin!or!similar!medication!recently;!
• Hydrate!the!patient!prior!to!the!examination!with!500!ml!of!water!orally!or!500!ml!of!NaCl!
0.9%!intravenously;!
• On!the!following!cases,!give!the!patient!diazepam/oxazepam!(with!a!dose!recommended!by!
the!physician)!15!minutes!prior!to!the!administration!of!FDG:!!
o PET>CT!scan! focused!on!head!and!neck,! to!prevent!harmful!accumulation!of!FDG! in!
the!cervical!musculature!and!vocal!cord!region;!
o Claustrophobia;!
o Tension/anxiety.!
!
Execution:*
• Give!the!patient!detailed!explanation!about!the!course!of!the!investigation;!
• Complete!the!acquisition!form;!
• Make!an!infusion!system!on!the!patient;!
o In! case! of! a! clinical! patient! that! has! an! infusion! of! over! 24! hours,! a! new! infusion!
system!should!be!applied.!If!the!patient!is!very!difficult!to!puncture!than!the!infusion!
that!he!has!must!be!checked!with!the!physician!if!it’s!good!enough!to!be!used;!!
• Take! blood! through! the! infusion! system! to! determine! the! glucose! value! with! "Glucocard!
Memory2";!
o At!values!>!10!mmol/l!consultation!should!follow!with!a!nuclear!medicine!physician!
before!proceeding!with!the!investigation;!
o Record!the!value!of!the!glucose!in!the!acquisition!form!and!the!application;!!
• The!nuclear!medicine!physician!in!training!injects!the!furosemide!and!then!the!FDG!(as!a!slow!
bolus)!intravenously!and!flushes!the!entire!system!with!20!ml!NaCl!0.9%;!
• The!patient!should!lay!down!approximately!60!minutes!before!starting!the!acquisitions;!
o Instruct! the! patient! to! lay! as! still! as! possible! and! avoid! talking! except! when! the!
patient!needs!to!use!the!bathroom;!
• Ask!the!patient!prior!to!the!start!of!the!scan!to!urinate;!
• Tell!the!patient!to!remove!every!metal!objects!in!the!FOV;!
• Position!the!patient!in!the!camera;!
o Adjust!the!table!height!so!that!the!patient!is!exactly!in!the!middle;!
• Perform!the!requested!scan!acquisitions;!
o Standard!whole!body!protocol!is!from!subtrochanter!to!skull;!
o 6>8!bed!positions!depending!on!the!length!patient;!
o 4!minutes!per!bed!position;!
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! Possibly!adjust!according!to!the!indication;!
! 3!min!/!BP!to!scan!when!including!legs;!
! 5!min!/!BP!when!low!on!activity;!
• Select!the!right!patient!with!the!right!investigation!in!the!browser.!
• Fill!in!the!required!fields:!
o Patient!weight;!
o Protocol:!
! Specials!→!PETCT_LD_WB_UMC;!
! Specials!→!PETCT_LD_WB_XL_UMCN!(for!scan!including!legs).!
o Patient!position;!
• Choose!Exam;!
• You!will!enter!the!Examination!tab;!
o Make!sure!Match!FOV!is!checked!in!the!box!PET!Planning;!
• Perform!an!AP!Topogram;!
• Set!the!region!of!interest!in!the!X>ray!image;!
o Standard!including!groin!and!upper!orbital;!
• Select!the!low!dose!CT!scan!and!check!the!selected!mAs;!
o Ref.!mAs:!50;!
o 120kV;!
! Change!kV!from!120!to!100!if!patient!weighs!less!than!70kg;!
o CARE!Dose4D!on;!
• Fill!in!all!the!PET!data;!
o Radiopharmaceutical!dose;!
o Injection!time;!
• Select!Load;!
• Move!the!patient’s!bed!to!the!PET’s!bed!position;!
• Select!Start!and!note!the!start!time!on!the!acquisition!form;!
• When!the!investigation!is!done,!choose!End!Study!in!the!Examination!tab;!
• Close!all!tabs!before!you!begin!a!new!study;!
o Protocol!→!unload!study;!
• Make!additional!recordings!on!indication;!
o See!CT!protocols;!
• Finally,!remove!the!patient!from!the!scan!table.!
!
Addition*to*standard*version*
!
Supplement*performance*scanning*with*legs:*
• Extend!ScanBed!with!additional!extension!on!top!of!standard!bed!extension;!
• Position!the!patient!with!arms!down!and!select!"Feet!First";!
• Select!the!acquisition!protocol:!PETCT_LD_WB_XL_UMCN;!
o PET:!1.5!min!per!bed!position!for!legs!and!3!minutes!per!bed!position!for!the!rest!of!
the!body;!
o On!indication,!the!time!per!bed!position!can!be!changed.!
!
Supplement*head/neck*Protocol:!
• Position!the!patient!with!arms!down!in!the!scanner;!
o Use!the!special!headrest!and!head!positioning!wedge;!
o Select!the!acquisition!protocol:!_PETCT_LD_WB_UMCN;!
o Set!in!2!bed!positions!head!to!clavicles;!
o PET:!5!min!per!bed!position;!
Masters in Nuclear Science Applied to Health, ESTESC 
The effects of weight and injected dose in the liver’s Signal-to-Noise Ratio in patients submitted to PET/CT scans 
Diogo Teixeira da Silva Duarte  55 
 
• Scan!the!rest!of!the!body!according!to!PETCT_LD_WB_UMCN!protocol;!
o From!clavicles!to!the!groin;!
o Patient’s!arms!up.!
!
*
Supplement*performance*in*suspected*presence*of*a*malignancy*in*the*pelvic*area:*
• Cervical! carcinoma,! endometrial! carcinoma,! chorionic! carcinoma,! bladder/ureters/renal!
pelvis!carcinoma,!among!others;!
!
Supplement* execution* with* proven/suspected* infection* in* heart/mediastinum,*
unexplained*high*fever*or*metastases*infection*research:!
• High! fever,!metastases! infections,! endocarditis,! pericarditis! and! cardiac! sarcoidosis,! among!
others;!
!
Scanner*and*computer*
!
Scanner:!!
• Siemens!MCT!PET;!
o UltraHD!and!TrueV!(extended!FOV);!
o 40!Spiral!CT!Adaptive!4D!slices;!
!
Acquisition:**
• Predefined!protocol;!
o Specials!→!PETCT_LD_WB_UMCN;!
o Specials!→!PETCT_LD_WB_XL_UMCN!(including!legs);!
!
Processing*
!
• Reconstruct!PET/CT!fused!images!using!TrueD!Siemens!application;!
• Go!to!the!Local!Database!using!the!patient!browser!and!select!the!correct!patient;!
• Send!to!"Hermes!and!Impax";!
o Patient!Protocol;!
o PET!WB;!
o PET!WB!UNCORRECTED;!
o PET!WB!NEDPAS;!
o Fused!transaxial!(only!to!IMPAX);!
o CT_3,!0_B31f;!
• Put!the!following!files!offline;!
o AC_CT;!
o Low!Dose!CT!3.0!B31;!
o Topogram;!
! Select!files!in!browser!and!direct!off>line!using!Transfer!→!Export!to!offline!
o PET!Raw!Data,!(=!incl!Normalisation);!
! Select!files!in!browser,!select!all!files!under!PET!Raw!Data!than!select!off>line!
using!Transfer!→!Export!to!offline.!
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III. Positioning of the point in the CT scan 
 
 
 
 
 
IV. Positioning of the point in the PET WB scan 
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V. Positioning of the point in the PET WB EANM scan 
 
 
VI. First ROI on CT scan 
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VII. First ROI on PET WB scan 
 
 
VIII. First ROI on PET WB EANM scan 
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IX. Second ROI on CT scan 
 
 
X. Second ROI on PET WB scan 
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XI. Second ROI on PET WB EANM scan 
 
 
XII. Third ROI on CT scan 
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XIII. Third ROI on PET WB scan 
 
 
XIV. Third ROI on PET WB EANM scan 
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XV. Fourth ROI on CT scan 
 
 
XVI. Fourth ROI on PET WB scan 
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XVII. Fourth ROI on PET WB EANM scan 
. 
 
XVIII. Fifth ROI on CT scan 
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XIX. Fifth ROI on PET WB scan 
 
 
XX. Fifth ROI on PET WB EANM scan 
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XXI. Values of the ROI's in the PET WB 
 
 
 
 
XXII. Values of the ROI's in the PET EANM WB 
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XXIII. Table of every value of every patient of PET WB 
 
 
XXIV. Table of every value of every patient of PET EANM WB 
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XXV. Relation between Weight and Dose Injected on the PET WB and PET WB EANM 
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XXVI. Relation between BMI and Dose Injected on the PET WB and PET WB EANM 
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XXVII. Relation between Dose Injected and SNR on the PET WB and PET WB EANM 
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XXVIII. Relation between BMI and SNR on the PET WB and PET WB EANM 
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XXIX. Relation between Weight and SNR on the PET WB and PET WB EANM 
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XXX. Equations 
 
 
WaD ×=  
SNRliver =
µliver
σ liver
 
µliver ∝Tliver  
σ liver ∝ (Tliver )n  
Tliver ∝DA ×F(X)  
µliver ∝DA ×F(X)  
σ liver ∝ (DA ×F(X))n  
SNRliver ∝
µliver
σ liver
∝ (DA )1−n ×F(X)1−n  
SNR*liver ∝
SNRliver
(DA )1−n  
SNR*liver = r1 × X × r2  
SNR*liver = r2 × Xr1  
SNR*liver = r2 × er1×X  
SNR*liver =
SNRstandard
(D 'T (X))1−n
 
D 'T (X) =
SNRstandard
SNR*liver
!
"
#
$
%
&
1
1−n
 
SNRstandard = SNRliver (X) = (DA )1−n ×F(X)1−n  
D 'T (X) = a×b×
r1,W ×b+ r2,W
r1,X × X + r2,X
"
#
$$
%
&
''
1
1−n
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D 'T (X) = a×b× r2,W( )
1
1−n ×b
r1
1−n × (r2,X )
−
1
1−n × X
−
r1
1−n  
D 'T (X) = a×b× r2,W( )
1
1−n × e
r1
1−n×b × (r2,X )
−
1
1−n × e
−
r1
1−n×X  
D 'T (X) =C1 ×
C2
r1,X × X + r2,X
"
#
$$
%
&
''
1
1−n
 
D 'T (X) =C3 × XC4  
D 'T (X) =C5 × eC6×X  
D 'T (X) =C3 ×WC4  
D 'T (X) =C5 × eC6×W  
D 'T (W )[MBq]= 0,0305×W[kg]1,889
SNR*liver = 0,537
SNRstandard = 6,1
 
D 'T (W )[MBq]=15, 41× e0,02546×W [kg]
SNR*liver = 0,550
SNRstandard = 6,2
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XXXI. Relation between SNR and ACliver from 5 to 3600s and 30 to 900s respectively 
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XXXII. Relation between Weight and SNR*liver in Clinical and EANM reconstructions 
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XXXIII. Relation between Weight and New SNRliver based on Power and Exponential 
Formulas 
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XXXIV. Relation between Weight and New dose based on Power and Exponential 
Formulas 
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XXXV. Relation between New Dose and New SNRliver based on Power and Exponential 
Formulas 
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XXXVI. Relation between the dose injected and the new dose based on Power and 
Exponential Formula 
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XXXVII. Equations for dosing schemes according to different references 
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XXXVIII. Different SNRs in different patients 
 
 
 
 
 
 
 
Weight: 105 Kg 
SNR: 4,69 
Injected dose: 168 MBq 
Glucose: 5,7 mmol/l 
Weight: 46 Kg 
SNR: 8,90 
Injected dose: 77 MBq 
Glucose: 4,2 mmol/l 
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Weight: 100 Kg 
SNR: 5,57 
Injected dose: 167 MBq 
Glucose: 5,2 mmol/l 
Weight: 86 Kg 
SNR: 6,15 
Injected dose: 138 MBq 
Glucose: 6,3 mmol/l 
Weight: 70 Kg 
SNR: 7,68 
Injected dose: 119 MBq 
Glucose: 6,4 mmol/l 
